Bortezomib and extramedullary disease in multiple myeloma: the shine and dark side of the moon.
Ali
Ridvan
R
Ozkalemkas
Fahir
F
Ozkan
Atilla
A
Ozkocaman
Vildan
V
Ozcelik
Tulay
T
Ozan
Ulku
U
Kurt
Meral
M
Tunali
Ahmet
A
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D010954:Plasmacytoma / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D011719:Pyrazines / Q000627:therapeutic use*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib